Suppr超能文献

中国乳腺癌幸存者对中医药使用的认知:一项定性研究。

Perceptions about traditional Chinese medicine use among Chinese breast cancer survivors: A qualitative study.

机构信息

Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.

出版信息

Cancer Med. 2023 Jan;12(2):1997-2007. doi: 10.1002/cam4.5046. Epub 2022 Sep 8.

Abstract

INTRODUCTION

An increasing number of breast cancer survivors (BCS) use traditional Chinese medicine (TCM) throughout their cancer journey. There is emerging evidence that TCM is effective in the reducing side effects of chemotherapy. However, qualitative patient-centric and culturally relevant research into TCM use is scant. This qualitative study aimed to explore the use and perceptions of Chinese Hong Kong BCS using TCM.

METHODS

Participants were recruited from a university hospital and three breast cancer patient groups in Hong Kong. Questionnaires regarding the use of TCM were given to all participants, followed by individual semi-structured interviews on selected BCS to comprehensively understand TCM's use and perceptions. A greater emphasis was placed on the qualitative data.

RESULTS

About half of the participants (n = 67, 48.9%) used TCM during their cancer treatment journey, among which almost all (n = 64, 95.5%) had improved symptoms. Sleeping disturbances (n = 58, 86.6%) and fatigue (n = 53, 79.1%) were the two most common symptoms that improved after TCM. Interview data revealed that participants used TCM to satisfy unmet needs that mainstream conventional Western medicine could not fulfil. They wished for a sense of control and better well-being. They expressed improvements in physical and psychological well-being after the use of TCM. Despite existing barriers, including high cost, long duration of treatment, and disapproval from oncologists, most would still recommend TCM to fellow survivors.

CONCLUSIONS

Chinese Hong Kong BCS who used TCM reported positive experiences. Understanding how BCS perceive and use TCM is important to integrating TCM into survivorship care in this population.

摘要

简介

越来越多的乳腺癌幸存者(BCS)在癌症治疗过程中使用传统中医(TCM)。有新证据表明 TCM 可有效减轻化疗副作用。然而,关于 TCM 使用的以患者为中心且具有文化相关性的定性研究却很少。本定性研究旨在探索香港乳腺癌幸存者使用 TCM 的情况和认知。

方法

参与者均来自香港一所大学医院和三个乳腺癌患者团体。所有参与者都被发放了关于 TCM 使用的问卷,然后对选定的 BCS 进行单独的半结构式访谈,以全面了解 TCM 的使用情况和认知。更注重定性数据。

结果

约一半的参与者(n=67,48.9%)在癌症治疗过程中使用了 TCM,其中几乎所有人(n=64,95.5%)的症状都有所改善。TCM 改善的最常见症状是睡眠障碍(n=58,86.6%)和疲劳(n=53,79.1%)。访谈数据显示,参与者使用 TCM 是为了满足主流常规西医无法满足的未满足需求。他们希望获得掌控感和更好的幸福感。他们表示在使用 TCM 后,身体和心理健康都有所改善。尽管存在成本高、治疗时间长以及肿瘤医生反对等障碍,但大多数人仍会向其他幸存者推荐 TCM。

结论

使用 TCM 的中国香港 BCS 报告了积极的体验。了解 BCS 如何看待和使用 TCM 对于将 TCM 融入该人群的生存护理至关重要。

相似文献

引用本文的文献

本文引用的文献

1
Estimated Projection of US Cancer Incidence and Death to 2040.预估 2040 年美国癌症发病与死亡人数。
JAMA Netw Open. 2021 Apr 1;4(4):e214708. doi: 10.1001/jamanetworkopen.2021.4708.
4
Breast Cancer Survivorship, Quality of Life, and Late Toxicities.乳腺癌幸存者、生活质量及晚期毒性反应
Front Oncol. 2020 Jun 16;10:864. doi: 10.3389/fonc.2020.00864. eCollection 2020.
5
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
6
Grounded theory research: A design framework for novice researchers.扎根理论研究:新手研究者的设计框架。
SAGE Open Med. 2019 Jan 2;7:2050312118822927. doi: 10.1177/2050312118822927. eCollection 2019.
8
Nephrotoxicity and Chinese Herbal Medicine.肾毒性与中草药。
Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1605-1611. doi: 10.2215/CJN.11571017. Epub 2018 Apr 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验